Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women.

scientific article published in August 2002

Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1029111495
P356DOI10.1007/BF02574481
P698PubMed publication ID12167579

P50authorKimberly Van ZeeQ48061295
Alexandra HeerdtQ56885122
P2093author name stringHoward T Thaler
Patrick I Borgen
Hiram S Cody
Leslie L Montgomery
Jeanne A Petrek
Larissa K F Temple
Jane V Fey
Roberta Baron
P2860cites workPain and other symptoms during the first year after radical and conservative surgery for breast cancerQ36136434
P433issue7
P921main subjectlymph nodeQ170758
P304page(s)654-662
P577publication date2002-08-01
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleSensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women
P478volume9

Reverse relations

cites work (P2860)
Q36694923200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up
Q53573091A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.
Q34075798A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Q37950837Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review
Q50486948Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Q37740946Clinical applications of breast pathology: management of in situ breast carcinomas and sentinel node biopsy issues
Q36648233Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
Q91675037High Frame Rate Contrast-Enhanced Ultrasound Imaging for Slow Lymphatic Flow: Influence of Ultrasound Pressure and Flow Rate on Bubble Disruption and Image Persistence
Q46372462Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience
Q99579050Long non-coding RNAs lnc-ANGPTL1-3:3 and lnc-GJA10-12:1 present as regulators of sentinel lymph node metastasis in breast cancer
Q36177518Lymphoedema: estimating the size of the problem.
Q24815529Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer
Q80161117Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
Q50249271Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer
Q43611760Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer
Q91264496Pre-operative Conventional Ultrasound and Sonoelastography Evaluation for Predicting Axillary Lymph Node Metastasis in Patients with Malignant Breast Lesions
Q85887366Pre-operative Ultrasonographic Evaluation of Axillary Lymph Nodes in Breast Cancer Patients: For Which Group Still of Additional Value and in Which Group Cause for Special Attention?
Q39553822Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications
Q37119431Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors
Q36169517Psychologic and social sequelae of secondary lymphedema: a review
Q56553878Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
Q34704773Risk of decline in upper-body function and symptoms among older breast cancer patients
Q37509569Sentinel Lymph Node Biopsy and Management of the Axilla in Ductal Carcinoma In Situ
Q36584805Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery
Q73792145Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma
Q53562393Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.
Q37281010The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up
Q59721943The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures
Q33986146Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
Q24815784Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature
Q50490813Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
Q79799361[Axillar lymphadenectomy]

Search more.